Loading clinical trials...
Loading clinical trials...
Fluorescein-Induced Acute Kidney Injury in Patients With Diabetes and Chronic Kidney Disease
Our study hypothesizes that fluorescein exposure in diabetic patients with advanced chronic kidney disease results in deterioration of kidney function. It will therefore aim to evaluate the incidence of acute kidney injury induced by fluorescein in diabetic patients with CKD. The objective is to determine the incidence, severity and risk factors associated with this deterioration to improve the care of this specific population.
This study will assess the change in serum creatinine in patients with diabetes and advanced chronic kidney disease, after a fluorescein angiography. This is a before and after study that will include 35 patients from the department of ophtalmology over 6 months with a total follow-up for 3 months.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Faculty of Medicine, Saint Joseph University of Beirut
Beirut, Lebanon
Start Date
January 7, 2025
Primary Completion Date
October 10, 2025
Completion Date
October 10, 2025
Last Updated
January 7, 2025
35
ESTIMATED participants
Fluorescein angiography
DIAGNOSTIC_TEST
Lead Sponsor
Saint-Joseph University
NCT06495385
NCT07446296
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions